Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of Hybridoma
Wu, Paul
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 27 grants from Paul Wu
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Project 3: Evaluation of Guanfacine on Drinking Behavior in Women and Men with Alcohol Use Disorders
Structure and Function of Copper Transporters
Gene Targeting By Triple Helix Forming Oligonucleotides
Regulation of Lrp Expression and Function in the CNS
Collaborative Proposal: Postseismic deformation of the Izmit-Duzce, Turkey earthquake sequence: implications for the mechanics of the earthquake cycle and rheology of the continent
Recently added grants:
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
Hemolysis and Platelet Activation during Continuous Flow Mechanical Circulatory Support
Defining and Controlling Airway Disease
Inactivation Mechanisms of Microvascular Hyperpermeability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44AI062594-003
Application #
3595492
Study Section
Project Start
1986-08-01
Project End
1988-07-31
Budget Start
1987-09-11
Budget End
1988-07-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
NIH 1986
N44 AI
Production of Hybridoma
Wu, Paul / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant